OW
OWPC.US One World Pharma Inc
- Market cap
- USD 36.0K
- P/E
- 0.0x
- P/B
- 12.63x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2025.
Is OWPC.US undervalued?
Graham numberThe Graham number of One World Pharma Inc cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
One World Pharma Inc fundamental analysis
No fundamental analysis for One World Pharma Inc yet.
One World Pharma Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About One World Pharma Inc
One World Products, Inc. engages in the provision of renewable and sustainable materials. It processes rubber, cellulose, hemp, and a range of bio-feedstocks into composites for automotive, industrial, and food packaging. The company was founded in 2018 and is headquartered in Las Vegas, Nevada.
Full company profileOne World Pharma Inc financial statements
2025 annualized: Fiscal year 2025 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2025, the balance sheet is the latest quarter. Figures change when the annual report is published.
One World Pharma Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 0.00 | 0.00 | 0.00 | 60.8K | 59.6K | 38.3K | 126K | 7.59K | 4.86K | 68.8K |
| Gross Profit | - | - | - | 0.00 | -45.2K | 18.5K | -175K | -166K | 3.92K | 66.6K |
| Operating Income | -36.7K | -56.9K | -27.0K | -5.72M | -7.92M | -3.23M | -2.24M | -2.08M | -1.71M | -1.10M |
| EBITDA | - | - | - | -5.80M | -7.88M | -3.23M | -2.43M | -3.61M | -2.89M | 7.17M |
| Net Income | -21.9K | -56.9K | -27.0K | -6.21M | -7.97M | -3.78M | -3.06M | -3.95M | -3.94M | 6.33M |
| EPS | - | -0.04 | -0.02 | -0.14 | -0.15 | -0.06 | -0.05 | -0.05 | -0.04 | 0.06 |
| Balance Sheet | ||||||||||
| Total Assets | 0.00 | 0.00 | 701.00 | 1.85M | 1.41M | 2.90M | 3.17M | 98.9K | 68.3K | 6.62M |
| Total Liabilities | 41.5K | 98.3K | 420.00 | 1.59M | 1.86M | 1.72M | 9.00M | 8.45M | 9.98M | 11.8M |
| Shareholders' Equity | -41.5K | -98.3K | 281.00 | 261K | -451K | 1.18M | -5.84M | -8.35M | -9.91M | -5.17M |
| Cash & Short-term Investments | 0.00 | 0.00 | 0.00 | 282K | 28.9K | 120K | 11.0K | 726.00 | 42.5K | 169K |
| Cash Flow | ||||||||||
| Operating Cash Flow | -33.8K | -187K | -1.69M | -4.06M | -1.43M | -3.73M | -1.38M | -1.19M | -1.12M | -792K |
| Capital Expenditure | 0.00 | 478K | 478K | 365K | 62.6K | 393K | 43.2K | 5.05K | 75.0K | 0.00 |
| Free Cash Flow | - | -57.3K | -37.9K | -4.43M | -1.49M | -4.12M | -1.42M | -1.20M | -1.20M | -792K |
| Ratios | ||||||||||
| ROE | - | - | -9,595.7% | -2,374.6% | - | -320.8% | - | - | - | - |
| ROA | - | - | -3,846.5% | -336.0% | -565.9% | -130.4% | -96.6% | -3,998.0% | -5,761.4% | 95.5% |
| Net Profit Margin | - | - | - | -10,211.5% | -13,371.5% | -9,890.7% | -2,434.7% | -52,092.8% | -80,917.4% | 9,190.7% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
One World Pharma Inc dividends
One World Pharma Inc has not paid dividends in the last 9 fiscal years.
Last stock split: 1:4 on Jan 10, 2019.
Who owns One World Pharma Inc
- Insiders 38.69%
- Institutions 0.00%
- Public & others 61.31%
- Shares outstanding 120M
- Free float 90.5M
One World Pharma Inc company profile
- Company name
- One World Pharma Inc
- Ticker
- OWPC.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Employees
- 2
- Fiscal year end
- December
- Address
- 6605 Grand Montecito Pkwy, Las Vegas, NV, United States, 89149
- Phone
- 800 605 3210
- Website
- oneworldproducts.com
About One World Pharma Inc
One World Products, Inc. engages in the provision of renewable and sustainable materials. It processes rubber, cellulose, hemp, and a range of bio-feedstocks into composites for automotive, industrial, and food packaging. The company was founded in 2018 and is headquartered in Las Vegas, Nevada.
One World Pharma Inc management
3- Mr. Isiah L. Thomas IIIExecutive Chairman of the Board, CFO & CEO · born 1961
- Mr. Filmoore WalkerChief Operating Officer
- Fukuji SaotomePresident of Eco Bio Plastics Midland